Expanding ADC Target Applications Through Innovative Linker Payload Chemistry Releasing Payload Without Internalization

  • Utilizing novel linker chemistry to circumvent the need for ADC internalization for payload release
  • Applying novel linker payload technology to unlock development against previously inaccessible ADC targets
  • Demonstrating novel target accessibility through preclinical efficacy and safety data of anti-VEGF avastin ADC YL242